AU5774699A - Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders - Google Patents
Human stearoyl-coa desaturase-related compositions and methods for treating skin disordersInfo
- Publication number
- AU5774699A AU5774699A AU57746/99A AU5774699A AU5774699A AU 5774699 A AU5774699 A AU 5774699A AU 57746/99 A AU57746/99 A AU 57746/99A AU 5774699 A AU5774699 A AU 5774699A AU 5774699 A AU5774699 A AU 5774699A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- skin disorders
- treating skin
- related compositions
- coa desaturase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USNOTGIVEN | 1997-05-09 | ||
| US9652098P | 1998-08-14 | 1998-08-14 | |
| US60096520 | 1998-08-14 | ||
| PCT/US1999/018387 WO2000009754A2 (en) | 1998-08-14 | 1999-08-12 | HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5774699A true AU5774699A (en) | 2000-03-06 |
Family
ID=22257742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU57746/99A Abandoned AU5774699A (en) | 1998-08-14 | 1999-08-12 | Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR020190A1 (en) |
| AU (1) | AU5774699A (en) |
| CO (1) | CO5280032A1 (en) |
| WO (1) | WO2000009754A2 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19955349A1 (en) * | 1999-11-17 | 2001-08-02 | Switch Biotech Ag | Use of novel polypeptide or its variant or nucleic acid encoding the polypeptide for diagnosing and/or preventing and/or treating skin disorders and/or treatment in wound healing or for identifying active substances |
| EP1315831B8 (en) | 2000-02-24 | 2010-09-01 | Xenon Pharmaceuticals Inc. | Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| US6686185B1 (en) | 2000-03-07 | 2004-02-03 | Millennium Pharmaceuticals, Inc. | 25934, a novel fatty acid desaturase and uses therefor |
| DE60134995D1 (en) | 2000-09-26 | 2008-09-04 | Xenon Pharmaceuticals Inc | METHOD AND COMPOSITIONS USING A STEAROYL-COA DESUTURASE-HSCD5 |
| WO2002040666A2 (en) * | 2000-11-17 | 2002-05-23 | Xenon Genetics Inc. | Fat regulated genes, uses thereof, and compounds for modulating same |
| US20050043256A1 (en) | 2001-07-30 | 2005-02-24 | Isis Pharmaceuticals, Inc. | Antisense modulation of stearoyl-CoA desaturase expression |
| US7132529B2 (en) | 2001-07-30 | 2006-11-07 | Isis Pharmaceuticals, Inc. | Antisense modulation of stearoyl-CoA desaturase expression |
| WO2003019146A2 (en) | 2001-08-29 | 2003-03-06 | Xenon Genetics Inc. | High throughput screening assays using fatty acid synthetic enzymes |
| AU2003213606A1 (en) * | 2002-03-01 | 2003-10-13 | Exelixis, Inc. | MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| AU2003294446A1 (en) * | 2002-11-21 | 2004-06-18 | Bayer Pharmaceuticals Corporation | Regulation of stearoyl-coa desaturase to treat obesity |
| FR2853910B1 (en) * | 2003-04-16 | 2007-08-24 | Galderma Res & Dev | GENES OF PSORIASIS |
| US7759348B2 (en) * | 2003-07-30 | 2010-07-20 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| US8802167B2 (en) | 2010-06-11 | 2014-08-12 | Avon Products, Inc. | Use of Eclipta prostrata and other PPAR-gamma inhibitors in cosmetics and compositions thereof |
| EP2711015B1 (en) | 2011-05-19 | 2016-06-29 | Toray Industries, Inc. | Immunity induction agent |
| CN108699589B (en) | 2016-07-08 | 2021-08-13 | 花王株式会社 | Method for preparing nucleic acid sample |
-
1999
- 1999-08-12 AU AU57746/99A patent/AU5774699A/en not_active Abandoned
- 1999-08-12 WO PCT/US1999/018387 patent/WO2000009754A2/en not_active Application Discontinuation
- 1999-08-13 AR ARP990104075A patent/AR020190A1/en unknown
- 1999-08-17 CO CO99051951A patent/CO5280032A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO5280032A1 (en) | 2003-05-30 |
| AR020190A1 (en) | 2002-05-02 |
| WO2000009754A2 (en) | 2000-02-24 |
| WO2000009754A3 (en) | 2000-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6872498A (en) | Method and composition for skin treatment | |
| GR980300033T1 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| IL142132A0 (en) | Methods and compositions for treating receptor mediated diseases | |
| EP0815838A3 (en) | External skin treatment composition | |
| AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
| AU2327599A (en) | Compositions and methods for treating autoimmune diseases | |
| EP0892632A4 (en) | Compositions useful in the phototherapeutic treatment of proliferative skin disorders | |
| AU5774699A (en) | Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders | |
| IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
| EP1109548A4 (en) | Compositions and methods for treating and preventing bone diseases using tocotrienols | |
| AU3082699A (en) | Method of treating skin irritation | |
| AU2804297A (en) | Method of and composition for treating disorders of the skin using vitamin k | |
| AU3204899A (en) | Hair treatment composition and method | |
| IL111554A0 (en) | Methods and compositions for hair treatment | |
| AU7106300A (en) | Treatment of skin disorders | |
| AU2068295A (en) | Skin treatment composition | |
| IL131347A0 (en) | Treatment of skin disorders | |
| AU2420101A (en) | Method and composition for the treatment of pain | |
| AU2509801A (en) | Method for the cosmetic treatment of human skin | |
| HUP0300043A3 (en) | Method and composition for the treatment of pain | |
| IL140005A0 (en) | Method of treatment for dermatological disorders and compositions therefor | |
| ZA952120B (en) | Skin treatment composition | |
| AU3887399A (en) | Hair and skin treatment method and composition | |
| AU6592496A (en) | Compositions and methods for treating specific gene expression-related diseases and disorders in humans | |
| AU3309697A (en) | Compositions and methods for treating specific gene expression-related diseases and disorders in humans |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |